The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, S. L.
Right arrow Articles by Kushner, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, S. L.
Right arrow Articles by Kushner, I.

The Journal of Immunology, Vol 154, Issue 2 825-831, Copyright © 1995 by American Association of Immunologists


ARTICLES

Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-1 beta involves both transcriptional and post-transcriptional mechanisms

SL Jiang, G Lozanski, D Samols and I Kushner
Department of Medicine, MetroHealth Medical Center, Cleveland, OH 44109.

Previous studies of murine serum amyloid A (SAA) regulation during inflammatory states or following exposure to macrophage-conditioned medium have raised the possibility that both post-transcriptional and transcriptional mechanisms participate in induction of this family of proteins. Since IL-6 and IL-1 have been shown to induce SAA in human hepatoma cell lines, we explored the possibility that these cytokines might induce human SAA through post-transcriptional as well as transcriptional mechanisms. In kinetic studies, we found that continuous exposure of Hep 3B cells to either IL-6 or IL-1 beta alone caused only minimal increases in SAA mRNA and marginal increases in transcription (as measured by nuclear runon). In contrast, the combination of these cytokines led to a 23-fold increase in transcription, maximal at 12 h, with continuing increase in mRNA, achieving levels more than 1,000-fold greater than baseline by 72 h. This massive disparity between increases in mRNA and in transcription rate strongly supports the participation of post-transcriptional mechanisms in SAA induction by (IL-6 + IL-1 beta), whereas the lag between peaks of transcription and mRNA abundance reflects a relatively slow degradation rate of SAA mRNA. As observed by other workers, mean size of SAA mRNA decreased progressively over the course of incubation. Simultaneous kinetic studies of complement factors B and C3, haptoglobin, and alpha-1 protease inhibitor revealed several different patterns of response to IL-6 and IL-1 beta.


This article has been cited by other articles:


Home page
J Med MicrobiolHome page
M. Jacobson, C. Fellstrom, R. Lindberg, P. Wallgren, and M. Jensen-Waern
Experimental swine dysentery: comparison between infection models
J. Med. Microbiol., April 1, 2004; 53(4): 273 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. B. Longley, D. M. Steel, and A. S. Whitehead
Posttranscriptional Regulation of Acute Phase Serum Amyloid A2 Expression by the 5'- and 3'-Untranslated Regions of Its mRNA
J. Immunol., October 15, 1999; 163(8): 4537 - 4545.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Ray, H. Schatten, and B. K. Ray
Activation of Sp1 and Its Functional Co-operation with Serum Amyloid A-activating Sequence Binding Factor in Synoviocyte Cells Trigger Synergistic Action of Interleukin-1 and Interleukin-6 in Serum Amyloid A Gene Expression
J. Biol. Chem., February 12, 1999; 274(7): 4300 - 4308.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Ray and A. Ray
Induction of Serum Amyloid A (SAA) Gene by SAA-activating Sequence-binding Factor (SAF) in Monocyte/Macrophage Cells. EVIDENCE FOR A FUNCTIONAL SYNERGY BETWEEN SAF AND Sp1
J. Biol. Chem., November 14, 1997; 272(46): 28948 - 28953.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ren and W. S.-L. Liao
Transcription Factor AP-2 Functions as a Repressor That Contributes to the Liver-specific Expression of Serum Amyloid A1 Gene
J. Biol. Chem., May 18, 2001; 276(21): 17770 - 17778.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.